Mangaceuticals Inc. (MGRX) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Mangaceuticals Inc. (MGRX:NASDAQ), powered by AI.

Current Price
$0.33
Sector
Healthcare
What is the Mangaceuticals Inc. stock price forecast?

Mangaceuticals Inc. is currently trading at $0.33. View real-time AI analysis on Alpha Lenz.

What is Mangaceuticals Inc. insider trading activity?

View the latest insider trading data for Mangaceuticals Inc. on Alpha Lenz.

What is Mangaceuticals Inc.'s P/E ratio?

View Mangaceuticals Inc.'s valuation metrics on Alpha Lenz.

Mangaceuticals Inc.

NASDAQ · MGRX
$0.33-0.03(-7.22%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Mangaceuticals Inc.'s future dividend policy...
Alpha Chat Insight

Mangaceuticals Inc.'s ROE is -141.6%. Explore profitability and growth together.

Ask for details

Company Overview

Mangaceuticals Inc. operates as a biotechnology company specializing in the development of plant-based pharmaceuticals. Its primary function is to harness the medicinal properties of exotic fruits and plants, particularly those with potential health benefits, to create pharmaceutical and nutraceutical products. Mangaceuticals Inc. focuses on research and innovation, employing cutting-edge biotechnological techniques to explore the therapeutic potential of natural compounds. The company's offerings have implications across multiple sectors, notably healthcare, wellness, and pharmaceuticals, as it seeks to provide natural alternatives to conventional medicines. The market significance of Mangaceuticals Inc. lies in its commitment to sustainability and the growing consumer demand for natural and holistic healthcare solutions. By integrating the principles of biotechnology and phytotherapy, the company positions itself at the forefront of a niche market segment that values environmental responsibility and health-conscious products. Mangaceuticals Inc. continues to expand its research and development capabilities, aiming to contribute to the evolving landscape of plant-based medicine and meet the needs of a health-aware global population.

CEOMr. Jacob D. Cohen
SectorHealthcare
IndustryHealth Information Services
Employees3

Company Statistics

FY 2025

Profile

N/AMarket Cap
$456.02KRevenue
0.00Shares Out
3Employees

Margins

54.91%Gross
-3822.36%EBITDA
-4200.46%Operating
-4526.86%Pre-Tax
-4526.86%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

270.88%Rev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-131.24%ROA
-141.65%ROE
-130.58%ROIC

Financial Health

$1.49MCash & Cash Equivalents
$-595.77KNet Debt
5.86%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Mangaceuticals Inc. (ticker: MGRX) is a company listed on NASDAQ in the Healthcare sector (Health Information Services). It has approximately 3 employees.

The current price is $0.334 with a P/E ratio of -x and P/B of -x.

ROE is -141.65% and operating margin is -4200.46%. Annual revenue is $456,021.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Mangaceuticals Inc. (MGRX) Stock Forecast 2026 $0.33 — Price, Financials & Analyst Targets | Alpha Lenz